在Charcot-Marie-Tooth疾病中用于步态和平衡的物理治疗干预:一个范围审查
Roberto Tedeschi1, Danilo Donati2,3, Federica Giorgi4
1Independent Researcher, 40100 Bologna, Italy.
Life (Basel, Switzerland)
|July 29, 2025
概括
在Charcot-Marie-Tooth疾病 (CMT) 中,物理治疗可以改善步态和平衡. 多模式康复是有前途的,但为了获得最佳的患者护理,需要对标准化方法进行更多的研究.
科学领域:
- 神经学 神经学
- 物理疗法物理治疗
- 康复医学 康复医学 康复医学
背景情况:
- 查洛-玛丽-牙病 (CMT) 是一种渐进的遗传性神经病变,导致移动性,平衡性和力量缺陷.
- 康复对于CMT管理至关重要,但干预的范围和有效性尚未明确.
- 本综述绘制了CMT患者的步态和平衡的物理治疗干预措施.
研究的目的:
- 在Charcot-Marie-Tooth病 (CMT) 中绘制和总结用于步态和平衡的物理治疗干预措施.
- 确定CMT康复的常用策略,方法限制和临床影响.
- 突出当前研究的差距,并指导未来的研究.
主要方法:
- 根据乔安娜·布里格斯研究所 (JBI) 和PRISMA-ScR指南进行范围审查.
- 在2024年3月之前,对五个数据库 (PubMed,Cochrane,PEDro,Scopus,Web of Science) 进行系统搜索.
- 包括对接受康复治疗的CMT患者进行功能结果的研究,并提取研究特征,方法和结果的数据.
主要成果:
- 包括11项研究 (案例报告,队列研究,2项RCT).
- 干预包括有氧训练,力量/平衡练习,视频游戏计划和多学科康复.
- 大多数研究报告说,尽管有方法上的限制,但行走能力,平衡,下肢力量,疲劳和生活质量都有所改善.
结论:
- 康复干预措施在CMT患者中带来了显著的功能改善.
- 量身定制的多式联运方法显示出管理CMT症状的潜力.
- 需要标准化的协议和结果措施来优化患者护理,并定义最佳实践.
更多相关视频
11:06A Human-machine-interface Integrating Low-cost Sensors with a Neuromuscular Electrical Stimulation System for Post-stroke Balance Rehabilitation
Published on: April 12, 2016
10.5K
08:24Sit-to-stand-and-walk from 120% Knee Height: A Novel Approach to Assess Dynamic Postural Control Independent of Lead-limb
Published on: August 30, 2016
10.3K
相关概念视频
Parkinson's Disease: Treatment
381
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
381
Parkinson's Disease: Overview
710
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
710
